INDIANAPOLIS--(BUSINESS WIRE)--In a ruling on September 28, 2012 in the U.S. District Court, Middle District of North Carolina, two affiliates of Dow AgroSciences (NYSE: DOW) received a $5.3 million award against Bayer Bioscience in a lawsuit over Bayer’s Bacillus thuringiensis biotechnology patents that were ultimately found in multiple legal proceedings to be unenforceable due to inequitable conduct.